{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:24:11Z","timestamp":1790627051293,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10072-020-04400-x","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:04:46Z","timestamp":1588374286000},"page":"2685-2690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Neurological manifestations of neurofibromatosis: a review"],"prefix":"10.1007","volume":"41","author":[{"given":"Michael","family":"Bayat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"issue":"8","key":"4400_CR1","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13(8):834\u2013843. https:\/\/doi.org\/10.1016\/S1474-4422(14)70063-8","journal-title":"Lancet Neurol"},{"issue":"4","key":"4400_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","volume":"6","author":"RE Ferner","year":"2007","unstructured":"Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 6(4):340\u2013351","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"4400_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510X(96)00022-6","volume":"138","author":"RE Ferner","year":"1996","unstructured":"Ferner RE, Hughes RA, Weinman J (1996) Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138(1\u20132):125\u2013133","journal-title":"J Neurol Sci"},{"issue":"21","key":"4400_CR4","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1200\/JCO.2016.71.7199","volume":"35","author":"J Campian","year":"2017","unstructured":"Campian J, Gutmann DH (2017) CNS tumors in neurofibromatosis. J Clin Oncol 35(21):2378\u20132385. https:\/\/doi.org\/10.1200\/JCO.2016.71.7199","journal-title":"J Clin Oncol"},{"key":"4400_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2007-973687","volume":"28","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch P (1997) An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1. Neuropediatrics 28:131\u2013132","journal-title":"Neuropediatrics"},{"issue":"2","key":"4400_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/5.2.116","volume":"5","author":"DN Korones","year":"2003","unstructured":"Korones DN, Padowski J, Factor BA, Constine LS (2003) Do children with optic pathway tumors have an increased frequency of other central nervous system tumors? Neuro Oncol 5(2):116\u2013112","journal-title":"Neuro Oncol"},{"issue":"1","key":"4400_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-017-0588-2","volume":"12","author":"L Sellmer","year":"2017","unstructured":"Sellmer L, Farschtschi S, Marangoni M, Heran MK, Birch P, Wenzel R, Friedman JM, Mautner VF (2017) Non-optic glioma in adults and children with neurofibromatosis 1. Orphanet J Rare Dis 12(1):34. https:\/\/doi.org\/10.1186\/s13023-017-0588-2","journal-title":"Orphanet J Rare Dis"},{"key":"4400_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/brain\/awg016","volume":"126","author":"J-S Guillamo","year":"2003","unstructured":"Guillamo J-S, Cr\u00e9ange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P (2003) Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1) a retrospective study of 104 patients. Brain 126:152\u2013160. https:\/\/doi.org\/10.1093\/brain\/awg016","journal-title":"Brain"},{"issue":"3","key":"4400_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/NEN.0b013e318165eb75","volume":"67","author":"FJ Rodriguez","year":"2008","unstructured":"Rodriguez FJ, Perry A, Gutmann DH, O\u2019Neill BP, Leonard J, Bryant S, Giannini C (2008) Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 67(3):240\u2013249. https:\/\/doi.org\/10.1097\/NEN.0b013e318165eb75","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"4400_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1212\/CPJ.0000000000000494","volume":"8","author":"JL Griffith","year":"2018","unstructured":"Griffith JL, Morris SM, Mahdi J, Goyal MS, Hershey T, Gutmann DH (2018) Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1. Neurol: Clin Pract 8(4):283\u2013291. https:\/\/doi.org\/10.1212\/CPJ.0000000000000494","journal-title":"Neurol: Clin Pract"},{"key":"4400_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11060-017-2475-z","volume":"133","author":"A Byrne","year":"2017","unstructured":"Byrne A, Connor A, Lascelles K, Siddiqui A, Hargrave D, Ferner RE (2017) Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas. J Neuro-Oncol 133:609\u2013614. https:\/\/doi.org\/10.1007\/s11060-017-2475-z","journal-title":"J Neuro-Oncol"},{"issue":"16","key":"4400_CR12","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1212\/WNL.0000000000003881","volume":"88","author":"J Mahdi","year":"2017","unstructured":"Mahdi J, Shah AC, Sato A, Morris SM, McKinstry RC, Listernick R, Packer RJ, Fisher MJ, Gutmann DH (2017) A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Neurology 88(16):1584\u20131589. https:\/\/doi.org\/10.1212\/WNL.0000000000003881","journal-title":"Neurology"},{"key":"4400_CR13","doi-asserted-by":"publisher","unstructured":"Rosenfeld A, Listernick R, Charrow J, Goldman S (2010) Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv Syst 26(5):663\u2013667. https:\/\/doi.org\/10.1007\/s00381-009-1024-2","DOI":"10.1007\/s00381-009-1024-2"},{"key":"4400_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.59.5.759","volume":"59","author":"DH Gutmann","year":"2002","unstructured":"Gutmann DH, Rasmussen SA, Wolkenstein P, MacCollin MM, Guha A, Inskip PD, North KN, Poyhonen M, Birch PH, Friedman JM (2002) Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology 59:759\u2013761","journal-title":"Neurology"},{"issue":"1","key":"4400_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12887-018-1067-1","volume":"18","author":"A D\u2019Amico","year":"2018","unstructured":"D\u2019Amico A, Mazio F, Ugga L, Cuocolo R, Cirillo M, Santoro C, Perrotta S, Melis D, Brunetti A (2018) Medullary unidentified bright objects in Neurofibromatosis type 1: a case series. BMC Pediatr 18(1):91. https:\/\/doi.org\/10.1186\/s12887-018-1067-1","journal-title":"BMC Pediatr"},{"issue":"4","key":"4400_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3174\/ajnr.A2357","volume":"32","author":"A Din\u00e7er","year":"2011","unstructured":"Din\u00e7er A, Yener U, \u00d6zek MM (2011) Hydrocephalus in patients with neurofibromatosis type 1: MR imaging findings and the outcome of endoscopic third ventriculostomy. AJNR Am J Neuroradiol 32(4):643\u2013646. https:\/\/doi.org\/10.3174\/ajnr.A2357","journal-title":"AJNR Am J Neuroradiol"},{"key":"4400_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.wneu.2017.08.053","volume":"107","author":"J Roth","year":"2017","unstructured":"Roth J, Ber R, Wisoff JH, Hidalgo ET, Limbrick DD, Berger DS, Thomale UW, Schulz M, Cinalli G, Santoro C, Constantini S (2017) Endoscopic third ventriculostomy in patients with neurofibromatosis type 1: a multicenter international experience. World Neurosurg 107:623\u2013629. https:\/\/doi.org\/10.1016\/j.wneu.2017.08.053","journal-title":"World Neurosurg"},{"issue":"2","key":"4400_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ajmg.a.20656","volume":"129A","author":"MA Kraut","year":"2004","unstructured":"Kraut MA, Gerring JP, Cooper KL, Thompson RE, Denckla MB, Kaufmann WE (2004) Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1. Am J Med Genet A 129A(2):113\u2013119","journal-title":"Am J Med Genet A"},{"issue":"3","key":"4400_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00247-007-0712-x","volume":"38","author":"JR Lopes Ferraz Filho","year":"2008","unstructured":"Lopes Ferraz Filho JR, Munis MP, Soares Souza A, Sanches RA, Goloni-Bertollo EM, Pavarino-Bertelli EC (2008) Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol 38(3):305\u2013310. https:\/\/doi.org\/10.1007\/s00247-007-0712-x","journal-title":"Pediatr Radiol"},{"issue":"8","key":"4400_CR20","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","volume":"54","author":"K DeBella","year":"2000","unstructured":"DeBella K, Poskitt K, Szudek J, Friedman JM (2000) Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54(8):1646\u20131651","journal-title":"Neurology"},{"key":"4400_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pediatrneurol.2018.07.005","volume":"86","author":"AD R\u00fcegger","year":"2018","unstructured":"R\u00fcegger AD, Coleman L, Hansford JR, McLean N, Dabscheck G (2018) Spinal cord hyperintensities in neurofibromatosis type 1: are they the cord equivalent of unidentified bright objects in the brain? Pediatr Neurol 86:63\u201365. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2018.07.005","journal-title":"Pediatr Neurol"},{"issue":"1","key":"4400_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0883073812441059","volume":"28","author":"PS Ghosh","year":"2013","unstructured":"Ghosh PS, Rothner AD, Emch TM, Friedman NR, Moodley M (2013) Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol 28(1):95\u2013101. https:\/\/doi.org\/10.1177\/0883073812441059","journal-title":"J Child Neurol"},{"issue":"3","key":"4400_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/jon.12160","volume":"25","author":"NM Giannantoni","year":"2015","unstructured":"Giannantoni NM, Broccolini A, Frisullo G, Pilato F, Profice P, Morosetti R, Di Lella G, Zampino G, Della MG (2015) Neurofibromatosis type 1 associated with vertebrobasilar dolichoectasia and pontine ischemic stroke. J Neuroimaging 25(3):505\u2013506. https:\/\/doi.org\/10.1111\/jon.12160","journal-title":"J Neuroimaging"},{"key":"4400_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S (2008) Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900\u2013904","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"4400_CR25","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.029","volume":"24","author":"K Hayashi","year":"2015","unstructured":"Hayashi K, Morofuji Y, Horie N, Izumo T (2015) A case of neurofibromatosis type 1 complicated with repeated intracerebral hemorrhage due to quasi-moyamoya disease. J Stroke Cerebrovasc Dis 24(5):e109\u2013e113. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.12.029","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"4400_CR26","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1086\/320121","volume":"68","author":"S Rasmussen","year":"2001","unstructured":"Rasmussen S, Yang Q, Friedman JM (2001) Mortality associated with neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68(5):1110\u20131118. https:\/\/doi.org\/10.1086\/320121","journal-title":"Am J Hum Genet"},{"issue":"3","key":"4400_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1212\/01.WNL.0000150544.00016.69","volume":"64","author":"TL Rosser","year":"2005","unstructured":"Rosser TL, Vezina G, Packer RJ (2005) Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 64(3):553\u2013555","journal-title":"Neurology"},{"issue":"10","key":"4400_CR28","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/jnnp.2007.136457","volume":"79","author":"AG Cairns","year":"2008","unstructured":"Cairns AG, North KN (2008) Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry 79(10):1165\u20131170. https:\/\/doi.org\/10.1136\/jnnp.2007.136457","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"4400_CR29","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1542\/peds.2009-0152","volume":"124","author":"D Rea","year":"2009","unstructured":"Rea D, Brandsema JF, Armstrong D, Parkin PC, deVeber G, MacGregor D, Logan WJ, Askalan R (2009) Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics 124(3):e476\u2013e483. https:\/\/doi.org\/10.1542\/peds.2009-0152","journal-title":"Pediatrics"},{"issue":"1","key":"4400_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/STROKEAHA.115.011406","volume":"47","author":"AR Terry","year":"2016","unstructured":"Terry AR, Jordan JT, Schwamm L, Plotkin SR (2016) Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: population-based approach. Stroke 47(1):60\u201365. https:\/\/doi.org\/10.1161\/STROKEAHA.115.011406","journal-title":"Stroke"},{"issue":"Pt 3","key":"4400_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/brain\/122.3.473","volume":"122","author":"A Cr\u00e9ange","year":"1999","unstructured":"Cr\u00e9ange A, Zeller J, Rostaing-Rigattieri S, Brugi\u00e8res P, Degos JD, Revuz J, Wolkenstein P (1999) Neurological complications of neurofibromatosis type 1 in adulthood. Brain 122(Pt 3):473\u2013481","journal-title":"Brain"},{"issue":"1","key":"4400_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1046\/j.1526-4610.1996.3601010.x","volume":"36","author":"M Clementi","year":"1996","unstructured":"Clementi M, Battistella PA, Rizzi L, Boni S, Tenconi R (1996) Headache in patients with neurofibromatosis type 1. Headache 36(1):10","journal-title":"Headache"},{"issue":"6","key":"4400_CR33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/ped.12375","volume":"56","author":"RS Pinho","year":"2014","unstructured":"Pinho RS, Fus\u00e3o EF, Paschoal JKSF, Caran EMM, Minett TSC, Vilanova LCP, Masruha MR (2014) Migraine is frequent in children and adolescents with neurofibromatosis type 1. Pediatr Int 56(6):865\u2013867. https:\/\/doi.org\/10.1111\/ped.12375","journal-title":"Pediatr Int"},{"issue":"4","key":"4400_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/088307380001500406","volume":"15","author":"FJ DiMario Jr","year":"2000","unstructured":"DiMario FJ Jr, Langshur S (2000) Headaches in patients with neurofibromatosis-1. J Child Neurol 15(4):235\u2013238","journal-title":"J Child Neurol"},{"issue":"10","key":"4400_CR35","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1002\/ajmg.a.37186","volume":"167A","author":"SK Afridi","year":"2015","unstructured":"Afridi SK, Leschziner GD, Ferner RE (2015) Prevalence and clinical presentation of headache in a National Neurofibromatosis 1 Service and impact on quality of life. Am J Med Genet A 167A(10):2282\u20132285. https:\/\/doi.org\/10.1002\/ajmg.a.37186","journal-title":"Am J Med Genet A"},{"key":"4400_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/jmg.2004.021683","volume":"41","author":"RE Ferner","year":"2004","unstructured":"Ferner RE, Hughes RAC, Hall SM, Upadhyaya M, Johnson MR (2004) Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). J Med Genet 41:837\u2013841. https:\/\/doi.org\/10.1136\/jmg.2004.021683","journal-title":"J Med Genet"},{"key":"4400_CR37","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/brain\/awh234","volume":"127","author":"A Drouet","year":"2004","unstructured":"Drouet A, Wolkenstein P, Lefaucheur J, Pinson S, Combemale P, Gherardi R, Brugieres P, Salama J, Ehre P, Decq P, Cr\u00e9ange A (2004) Neurofibromatosis 1-associated neuropathies: a reappraisal. Brain 127:1993\u20132009. https:\/\/doi.org\/10.1093\/brain\/awh234","journal-title":"Brain"},{"issue":"5","key":"4400_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0887-8994(98)00075-7","volume":"19","author":"K Kulkantrakorn","year":"1998","unstructured":"Kulkantrakorn K, Geller TJ (1998) Seizures in neurofibromatosis 1. Pediatr Neurol 19(5):347\u2013350","journal-title":"Pediatr Neurol"},{"issue":"5","key":"4400_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/08830738030180050501","volume":"18","author":"R Vivarelli","year":"2003","unstructured":"Vivarelli R, Grosso S, Calabrese F, Farnetani M, Di Bartolo R, Morgese G, Balestri P (2003) Epilepsy in neurofibromatosis 1. J Child Neurol 18(5):338\u2013342","journal-title":"J Child Neurol"},{"issue":"8","key":"4400_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","volume":"20","author":"HY Hsieh","year":"2011","unstructured":"Hsieh HY, Fung HC, Wang CJ, Chin SC, Wu T (2011) Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects. Seizure 20(8):606\u2013611. https:\/\/doi.org\/10.1016\/j.seizure.2011.04.016","journal-title":"Seizure"},{"issue":"10","key":"4400_CR41","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/epi.12348","volume":"54","author":"AP Ostendorf","year":"2013","unstructured":"Ostendorf AP, Gutmann DH, Weisenberg JL (2013) Epilepsy in individuals with neurofibromatosis type 1. Epilepsia 54(10):1810\u20131814. https:\/\/doi.org\/10.1111\/epi.12348","journal-title":"Epilepsia"},{"key":"4400_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","volume":"73","author":"A Pecoraro","year":"2017","unstructured":"Pecoraro A, Arehart E, Gallentine W, Radtke R, Smith E, Pizoli C, Kansagra S, Abdelnour E, McLendon R, Mikati MA (2017) Epilepsy in neurofibromatosis type 1. Epilepsy Behav 73:137\u2013141. https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.011","journal-title":"Epilepsy Behav"},{"issue":"3","key":"4400_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.eplepsyres.2013.02.021","volume":"105","author":"C Barba","year":"2013","unstructured":"Barba C, Jacques T, Kahane P, Polster T, Isnard J, Leijten FS, Ozkara C, Tassi L, Giordano F, Castagna M, John A, Oz B, Salon C, Streichenberger N, Cross JH, Guerrini R (2013) Epilepsy surgery in neurofibromatosis type 1. Epilepsy Res 105(3):384\u2013395. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.02.021","journal-title":"Epilepsy Res"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04400-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T13:03:12Z","timestamp":1620046992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04400-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4400"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04400-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"26 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}